Semaglutide, the active ingredient in Ozempic, and other drugs in the same class have revolutionized the treatment of obesity and type 2 diabetes. Now, a clinical trial suggests the medicines can ...

CHICAGO -- Semaglutide (Ozempic) reduced glucose levels and weight among patients with type 1 diabetes and obesity, a randomized trial showed. In this 26-week, double-blind trial of 72 adults, 36% ...

Here’s how it works. GLP-1 agonists, the class of drug that includes Ozempic, may be useful for managing type 1 diabetes. (Image credit: Tatsiana Volkava via Getty Images) ...

A new study finds the use of weight loss drugs like Ozempic, Wegovy, and Zepbound in people with Type-1 Diabetes has risen sharply. It comes even though there's little information on the drugs ...

GLP-1 agonists, including liraglutide, are typically used to control blood sugar levels in type 2 diabetes and to promote weight loss. These drugs mimic a hormone released after eating, helping to ...

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related cancers, especially colorectal cancer, according to data released on ...

A new stem cell treatment could eliminate the need for insulin therapy in people with type 1 diabetes, a disease where the ...

The medication labels for Ozempic and Mounjaro, which are prescribed to help people with type 2 diabetes manage blood sugar, specifically say they are not intended for use with type 1. However ...

More people with type 1 diabetes are using GLP-1s like Ozempic and Zepbound, a new study found. Researchers attribute the high demand to rising rates of obesity among people with type 1 diabetes.

A new experimental treatment may be able to cure type 1 diabetes. About 83% of the patients were able to stop using insulin after the treatment. Research into the treatment is ongoing.

Type 1 diabetes arises when a person’s immune system destroys beta cells, and they no longer make the needed amount of insulin to stay healthy. However, in the early stages of type 1 diabetes ...

Dual-action approach targeting inflammation shows potential as Type 1 diabetes treatment Date: May 7, 2025 Source: Indiana University Summary: A new strategy may help prevent or slow the ...